Healthy Clinical Trial
— LadotyriCTOfficial title:
Postprandial Inflammatory and Metabolic Responses Induced by the Authentic Ladotyri Mytilinis PDO Cheese and Italian Parmesan PDO Cheese
Verified date | April 2023 |
Source | University of the Aegean |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study was the investigation of the postprandial metabolic responses, after the intake of a traditional, Ladotyri Mytilinis cheese, compared to corresponding responses after an Italian Parmesan cheese consumption, in healthy participants.
Status | Completed |
Enrollment | 10 |
Est. completion date | January 17, 2022 |
Est. primary completion date | January 17, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility | Inclusion Criteria: - Age 18-65 years - Willingness to join and complete the nutritional intervention Exclusion Criteria: - Inability or unwillingness to provide informed consent - Three-month nutritional supplement - Age over 65 years or below 18 years - Chronic diseases history - Hemoglobin A1c - HbA1c > 5.7 % - Abnormal Body Mass Index (BMI) (> 25 kg / m2) - Abnormal hematological or biochemical profile (total cholesterol > 240 mg/dL, triglycerides > 250 mg/dL, glucose > 100 mg/dL) - Alcohol overdose (> 40 g alcohol / day) - Heavy smoking (> 10 cigarettes / day) - Concurrent participation in another intervention study or unconsciousness in previous blood draws |
Country | Name | City | State |
---|---|---|---|
Greece | University of the Aegean | Myrina |
Lead Sponsor | Collaborator |
---|---|
University of the Aegean | E.Thimelis Dairy S.A. |
Greece,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Changes from baseline of Total Antioxidant Capacity at 30 minutes, 1.5 hours and 3 hours | Plasma antioxidant activity | 3 hours | |
Secondary | Changes from baseline of total Cholesterol at 30 minutes, 1.5 hours and 3 hours | Serum total cholesterol levels | 3 hours | |
Secondary | Changes from baseline of High Density Lipoprotein cholesterol (HDL-) at 30 minutes, 1.5 hours and 3 hours | Serum High Density Lipoprotein levels | 3 hours | |
Secondary | Changes from baseline of Low Density Lipoprotein cholesterol (LDL-) at 30 minutes, 1.5 hours and 3 hours | Serum High Density Lipoprotein levels | 3 hours | |
Secondary | Changes from baseline of triglycerides at 30 minutes, 1.5 hours and 3 hours | Serum triglycerides levels | 3 hours | |
Secondary | Changes from baseline of glucose at 30 minutes, 1.5 hours and 3 hours | Serum glucose levels | 3 hours | |
Secondary | Changes from baseline of Uric Acid at 30 minutes, 1.5 hours and 3 hours | Serum uric acid levels | 3 hours |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |